Drug delivery from structured porous inorganic materials
Structured porous inorganic materials show high chemical and mechanical stability under an array of physiological conditions. Their hydrophilic character and porous structure can in principle be tailored to control the diffusion rate of an adsorbed or encapsulated drug, gene, or protein. This organi...
Gespeichert in:
Veröffentlicht in: | Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology 2012-01, Vol.4 (1), p.16-30 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 30 |
---|---|
container_issue | 1 |
container_start_page | 16 |
container_title | Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology |
container_volume | 4 |
creator | Arruebo, Manuel |
description | Structured porous inorganic materials show high chemical and mechanical stability under an array of physiological conditions. Their hydrophilic character and porous structure can in principle be tailored to control the diffusion rate of an adsorbed or encapsulated drug, gene, or protein. This organized porosity has been used to achieve a sustained, controlled, or pulsed release in drug delivery applications. Their large surface areas together with their large pore volumes have been used to improve the solubility of poorly soluble drugs. Their low density allows them to float in the gastrointestinal tract and prolong the gastric retention of oral drugs. In addition, their easy surface functionalization allows their grafting with bioadhesive and targeting moieties, and their interior pore volume protects biological payloads from physiological degradation. Some of those porous inorganic materials can be synthesized or microfabricated to form deposits thus acting as drug reservoirs. Finally, diffusion‐controlling porous membranes or coatings of those materials can be tailored with specific pore sizes to control drug release in eluting devices. Current research is focused on designing on demand targeted drug delivery systems using those inorganic porous materials as reservoirs together with triggering systems on their pore entrances to be externally activated to release the encapsulated therapeutic moiety. All of the previous scenarios will be overviewed to demonstrate the numerous possibilities of structured porous inorganic materials in drug delivery applications. WIREs Nanomed Nanobiotechnol 2012, 4:16–30. doi: 10.1002/wnan.132
This article is categorized under:
Implantable Materials and Surgical Technologies > Nanomaterials and Implants |
doi_str_mv | 10.1002/wnan.132 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_911947800</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1647011842</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5462-54a937314ba940bd1851feac4ec78cdff2ea233956197869886998654337a0353</originalsourceid><addsrcrecordid>eNqN0V1LHDEUBuBQKnWrQn9BGehFezN6Tr5zKdaqsCjKipchO5ORsfOxTWa0---N7LpCwaUX4eTi4c0JLyFfEA4RgB49da47REY_kAkaZnIAjh_Xd4Eod8nnGB8AJJdUfCK7FJnimqoJ0T_DeJ-VvqkffVhmVejbLA5hLIYx-DJb9KEfY1Z3fbh3XV1krRt8qF0T98lOlYY_WM89cvvrdHZynk-vzi5Ojqd5IdJjueDOMMWQz53hMC9RC6y8K7gvlC7KqqLeUcaMkGiUlkanY7QUnDHlgAm2R76vcheh_zP6ONi2joVvGtf5tJo1iIYrDZDkj60SpQQQTCL_D8oVIGpOE_32D33ox9ClL1sKoNLiafVtChUoDlyDfnu2CH2MwVd2EerWhaVFsC9F2pcibSoy0a_rwHHe-nIDX5tLIF-Bp7rxy3eD7N3l8eUqcO3rOPi_G-_CbysVUyLBMztjd9fmhik7Zc_m67JS</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1707404808</pqid></control><display><type>article</type><title>Drug delivery from structured porous inorganic materials</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Arruebo, Manuel</creator><creatorcontrib>Arruebo, Manuel</creatorcontrib><description>Structured porous inorganic materials show high chemical and mechanical stability under an array of physiological conditions. Their hydrophilic character and porous structure can in principle be tailored to control the diffusion rate of an adsorbed or encapsulated drug, gene, or protein. This organized porosity has been used to achieve a sustained, controlled, or pulsed release in drug delivery applications. Their large surface areas together with their large pore volumes have been used to improve the solubility of poorly soluble drugs. Their low density allows them to float in the gastrointestinal tract and prolong the gastric retention of oral drugs. In addition, their easy surface functionalization allows their grafting with bioadhesive and targeting moieties, and their interior pore volume protects biological payloads from physiological degradation. Some of those porous inorganic materials can be synthesized or microfabricated to form deposits thus acting as drug reservoirs. Finally, diffusion‐controlling porous membranes or coatings of those materials can be tailored with specific pore sizes to control drug release in eluting devices. Current research is focused on designing on demand targeted drug delivery systems using those inorganic porous materials as reservoirs together with triggering systems on their pore entrances to be externally activated to release the encapsulated therapeutic moiety. All of the previous scenarios will be overviewed to demonstrate the numerous possibilities of structured porous inorganic materials in drug delivery applications. WIREs Nanomed Nanobiotechnol 2012, 4:16–30. doi: 10.1002/wnan.132
This article is categorized under:
Implantable Materials and Surgical Technologies > Nanomaterials and Implants</description><identifier>ISSN: 1939-5116</identifier><identifier>EISSN: 1939-0041</identifier><identifier>DOI: 10.1002/wnan.132</identifier><identifier>PMID: 21374827</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>Animals ; Carbon - chemistry ; Delayed-Action Preparations ; Density ; Diffusion coatings ; Diffusion rate ; Drug delivery ; Drug delivery systems ; Drug Delivery Systems - methods ; Drugs ; Encapsulation ; Entrances ; Gastrointestinal tract ; Humans ; Inorganic Chemicals - chemistry ; Inorganic materials ; Materials Testing ; Membranes ; Nanomaterials ; Nanostructure ; Nanotechnology ; Payloads ; Physiology ; Porosity ; Porous materials ; Protective coatings ; Reservoirs ; Silicates - chemistry ; Surgery ; Surgical equipment ; Surgical implants ; Wire</subject><ispartof>Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology, 2012-01, Vol.4 (1), p.16-30</ispartof><rights>Copyright © 2011 John Wiley & Sons, Inc.</rights><rights>Copyright Wiley Subscription Services, Inc. Jan/Feb 2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5462-54a937314ba940bd1851feac4ec78cdff2ea233956197869886998654337a0353</citedby><cites>FETCH-LOGICAL-c5462-54a937314ba940bd1851feac4ec78cdff2ea233956197869886998654337a0353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fwnan.132$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fwnan.132$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21374827$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Arruebo, Manuel</creatorcontrib><title>Drug delivery from structured porous inorganic materials</title><title>Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology</title><addtitle>WIREs Nanomed Nanobiotechnol</addtitle><description>Structured porous inorganic materials show high chemical and mechanical stability under an array of physiological conditions. Their hydrophilic character and porous structure can in principle be tailored to control the diffusion rate of an adsorbed or encapsulated drug, gene, or protein. This organized porosity has been used to achieve a sustained, controlled, or pulsed release in drug delivery applications. Their large surface areas together with their large pore volumes have been used to improve the solubility of poorly soluble drugs. Their low density allows them to float in the gastrointestinal tract and prolong the gastric retention of oral drugs. In addition, their easy surface functionalization allows their grafting with bioadhesive and targeting moieties, and their interior pore volume protects biological payloads from physiological degradation. Some of those porous inorganic materials can be synthesized or microfabricated to form deposits thus acting as drug reservoirs. Finally, diffusion‐controlling porous membranes or coatings of those materials can be tailored with specific pore sizes to control drug release in eluting devices. Current research is focused on designing on demand targeted drug delivery systems using those inorganic porous materials as reservoirs together with triggering systems on their pore entrances to be externally activated to release the encapsulated therapeutic moiety. All of the previous scenarios will be overviewed to demonstrate the numerous possibilities of structured porous inorganic materials in drug delivery applications. WIREs Nanomed Nanobiotechnol 2012, 4:16–30. doi: 10.1002/wnan.132
This article is categorized under:
Implantable Materials and Surgical Technologies > Nanomaterials and Implants</description><subject>Animals</subject><subject>Carbon - chemistry</subject><subject>Delayed-Action Preparations</subject><subject>Density</subject><subject>Diffusion coatings</subject><subject>Diffusion rate</subject><subject>Drug delivery</subject><subject>Drug delivery systems</subject><subject>Drug Delivery Systems - methods</subject><subject>Drugs</subject><subject>Encapsulation</subject><subject>Entrances</subject><subject>Gastrointestinal tract</subject><subject>Humans</subject><subject>Inorganic Chemicals - chemistry</subject><subject>Inorganic materials</subject><subject>Materials Testing</subject><subject>Membranes</subject><subject>Nanomaterials</subject><subject>Nanostructure</subject><subject>Nanotechnology</subject><subject>Payloads</subject><subject>Physiology</subject><subject>Porosity</subject><subject>Porous materials</subject><subject>Protective coatings</subject><subject>Reservoirs</subject><subject>Silicates - chemistry</subject><subject>Surgery</subject><subject>Surgical equipment</subject><subject>Surgical implants</subject><subject>Wire</subject><issn>1939-5116</issn><issn>1939-0041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqN0V1LHDEUBuBQKnWrQn9BGehFezN6Tr5zKdaqsCjKipchO5ORsfOxTWa0---N7LpCwaUX4eTi4c0JLyFfEA4RgB49da47REY_kAkaZnIAjh_Xd4Eod8nnGB8AJJdUfCK7FJnimqoJ0T_DeJ-VvqkffVhmVejbLA5hLIYx-DJb9KEfY1Z3fbh3XV1krRt8qF0T98lOlYY_WM89cvvrdHZynk-vzi5Ojqd5IdJjueDOMMWQz53hMC9RC6y8K7gvlC7KqqLeUcaMkGiUlkanY7QUnDHlgAm2R76vcheh_zP6ONi2joVvGtf5tJo1iIYrDZDkj60SpQQQTCL_D8oVIGpOE_32D33ox9ClL1sKoNLiafVtChUoDlyDfnu2CH2MwVd2EerWhaVFsC9F2pcibSoy0a_rwHHe-nIDX5tLIF-Bp7rxy3eD7N3l8eUqcO3rOPi_G-_CbysVUyLBMztjd9fmhik7Zc_m67JS</recordid><startdate>201201</startdate><enddate>201201</enddate><creator>Arruebo, Manuel</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7QP</scope><scope>7TK</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7SR</scope><scope>F28</scope><scope>JG9</scope><scope>7X8</scope></search><sort><creationdate>201201</creationdate><title>Drug delivery from structured porous inorganic materials</title><author>Arruebo, Manuel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5462-54a937314ba940bd1851feac4ec78cdff2ea233956197869886998654337a0353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Animals</topic><topic>Carbon - chemistry</topic><topic>Delayed-Action Preparations</topic><topic>Density</topic><topic>Diffusion coatings</topic><topic>Diffusion rate</topic><topic>Drug delivery</topic><topic>Drug delivery systems</topic><topic>Drug Delivery Systems - methods</topic><topic>Drugs</topic><topic>Encapsulation</topic><topic>Entrances</topic><topic>Gastrointestinal tract</topic><topic>Humans</topic><topic>Inorganic Chemicals - chemistry</topic><topic>Inorganic materials</topic><topic>Materials Testing</topic><topic>Membranes</topic><topic>Nanomaterials</topic><topic>Nanostructure</topic><topic>Nanotechnology</topic><topic>Payloads</topic><topic>Physiology</topic><topic>Porosity</topic><topic>Porous materials</topic><topic>Protective coatings</topic><topic>Reservoirs</topic><topic>Silicates - chemistry</topic><topic>Surgery</topic><topic>Surgical equipment</topic><topic>Surgical implants</topic><topic>Wire</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arruebo, Manuel</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>ANTE: Abstracts in New Technology & Engineering</collection><collection>Materials Research Database</collection><collection>MEDLINE - Academic</collection><jtitle>Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arruebo, Manuel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Drug delivery from structured porous inorganic materials</atitle><jtitle>Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology</jtitle><addtitle>WIREs Nanomed Nanobiotechnol</addtitle><date>2012-01</date><risdate>2012</risdate><volume>4</volume><issue>1</issue><spage>16</spage><epage>30</epage><pages>16-30</pages><issn>1939-5116</issn><eissn>1939-0041</eissn><abstract>Structured porous inorganic materials show high chemical and mechanical stability under an array of physiological conditions. Their hydrophilic character and porous structure can in principle be tailored to control the diffusion rate of an adsorbed or encapsulated drug, gene, or protein. This organized porosity has been used to achieve a sustained, controlled, or pulsed release in drug delivery applications. Their large surface areas together with their large pore volumes have been used to improve the solubility of poorly soluble drugs. Their low density allows them to float in the gastrointestinal tract and prolong the gastric retention of oral drugs. In addition, their easy surface functionalization allows their grafting with bioadhesive and targeting moieties, and their interior pore volume protects biological payloads from physiological degradation. Some of those porous inorganic materials can be synthesized or microfabricated to form deposits thus acting as drug reservoirs. Finally, diffusion‐controlling porous membranes or coatings of those materials can be tailored with specific pore sizes to control drug release in eluting devices. Current research is focused on designing on demand targeted drug delivery systems using those inorganic porous materials as reservoirs together with triggering systems on their pore entrances to be externally activated to release the encapsulated therapeutic moiety. All of the previous scenarios will be overviewed to demonstrate the numerous possibilities of structured porous inorganic materials in drug delivery applications. WIREs Nanomed Nanobiotechnol 2012, 4:16–30. doi: 10.1002/wnan.132
This article is categorized under:
Implantable Materials and Surgical Technologies > Nanomaterials and Implants</abstract><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>21374827</pmid><doi>10.1002/wnan.132</doi><tpages>15</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1939-5116 |
ispartof | Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology, 2012-01, Vol.4 (1), p.16-30 |
issn | 1939-5116 1939-0041 |
language | eng |
recordid | cdi_proquest_miscellaneous_911947800 |
source | MEDLINE; Access via Wiley Online Library |
subjects | Animals Carbon - chemistry Delayed-Action Preparations Density Diffusion coatings Diffusion rate Drug delivery Drug delivery systems Drug Delivery Systems - methods Drugs Encapsulation Entrances Gastrointestinal tract Humans Inorganic Chemicals - chemistry Inorganic materials Materials Testing Membranes Nanomaterials Nanostructure Nanotechnology Payloads Physiology Porosity Porous materials Protective coatings Reservoirs Silicates - chemistry Surgery Surgical equipment Surgical implants Wire |
title | Drug delivery from structured porous inorganic materials |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T05%3A48%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Drug%20delivery%20from%20structured%20porous%20inorganic%20materials&rft.jtitle=Wiley%20interdisciplinary%20reviews.%20Nanomedicine%20and%20nanobiotechnology&rft.au=Arruebo,%20Manuel&rft.date=2012-01&rft.volume=4&rft.issue=1&rft.spage=16&rft.epage=30&rft.pages=16-30&rft.issn=1939-5116&rft.eissn=1939-0041&rft_id=info:doi/10.1002/wnan.132&rft_dat=%3Cproquest_cross%3E1647011842%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1707404808&rft_id=info:pmid/21374827&rfr_iscdi=true |